Head-to-head · WeighScore
HealthRX vs Loop Health
The verdict
HealthRX takes it — 86.1/100 to 70/100.
HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | HealthRX | Loop Health |
|---|---|---|
| WeighScore | 86.1/100 | 70/100 |
| Grade | B | C |
| Scorecard rank | #8 | #114 |
| Semaglutide | $189/mo | $79/mo (plus a separate fee, compounded) |
| Tirzepatide | $349/mo | $125/mo (annual plan, plus a separate fee, compounded) |
| Coverage | Not publicly listed | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #8 · B
Strengths
- LegitScript-certified (#50087439) — a genuine, verifiable trust signal
- Physician-supervised intake with licensed providers
- Both molecules plus a rare oral GLP tablet option
- Transparent flat monthly pricing, no insurance required
Where it loses points
- Compounded semaglutide/tirzepatide is not FDA-approved
- Some tiers are company-stated and the public site is thin
- Brand Ozempic is a steep pass-through (~$1,299)
- State count is not publicly listed
Graded #114 · C
Strengths
- Multi-product wellness platform — GLP-1 plus peptides, NAD+, coaching, bloodwork
- Low membership entry point ($79/mo)
- Annual plan includes monthly 'research credit' toward compounds
- Explicit compounded-drug FDA disclaimer on-site
Where it loses points
- Per-dose GLP-1 drug pricing not transparent on public site (compounds billed separately by pharmacy)
- States-served list not enumerated — only 'select U.S. states'
- Platform explicitly 'is not a healthcare provider' — relies on independent provider network
- No LegitScript number disclosed on homepage
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.